Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skin sterol identifies multivessel disease risk

This article was originally published in Clinica

Executive Summary

Measurements from IMI International Medical Innovations' noninvasive, point-of-care skin sterol test, PREVU, when combined with a patient's cardiac disease risk as classified by the Framingham global risk score, could pinpoint patients with a higher risk of multivessel disease - ie narrowing in two or more coronary vessels. So revealed a 649-patient study that found that when skin sterol and Framingham risk were both elevated, the likelihood of multivessel disease was four times greater. Toronto, Canada-based IMI has already received clearance to sell PREVU in the US, Canada and Europe for assessing coronary artery disease risk. In a separate announcement, the firm said it was launching a 78-patient pivotal clinical study of its non-invasive breast cancer detection test, which identifies a cancer-associated sugar in nipple-aspirate fluid.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055102

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel